On the Annals of Internal Medicine homepage, identify the title and the first two authors of the top 'Most Read Article'. Additionally, locate the 'Original Research' section and provide the title and publication date of the article 'Semaglutide, Dulaglutide, or Empagliflozin for Diabetes: Mortality and CV Outcomes'.
Navigate to 'https://annals.org'. Locate the 'Most Read Articles' section on the homepage. Identify the title of the first article listed under 'Most Read Articles'. Identify the first two listed authors of the first article under 'Most Read Articles'. Locate the 'Original Research' section on the homepage. Find the article titled 'Semaglutide, Dulaglutide, or Empagliflozin for Diabetes: Mortality and CV Outcomes' within the 'Original Research' section. Identify the publication date for 'Semaglutide, Dulaglutide, or Empagliflozin for Diabetes: Mortality and CV Outcomes'.
The agent successfully navigates to 'https://annals.org'. The agent correctly identifies the title of the top 'Most Read Article' as 'PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and...'. The agent correctly identifies the first two authors of the top 'Most Read Article' as 'Andrea C. Tricco, PhD, MSc' and 'Erin Lillie, MSc'. The agent correctly identifies the publication date of 'Semaglutide, Dulaglutide, or Empagliflozin for Diabetes: Mortality and CV Outcomes' as '17 June 2025'.